TAB3
TAB3 (TGF-beta activated kinase 1 and MAP3K7 binding protein 3, also known as MAP3K7IP3) is an adaptor protein that functions in the NF-kappaB signal transduction pathway. It partners with the kinase MAP3K7/TAK1 in response to pro-inflammatory cytokine stimulation. Browse Assay Genie's current range of TAB3 research reagents below, or read on for the biology behind the target.
The TAB3 protein functions in the NF-kappaB signal transduction pathway. Together with the similar and functionally redundant protein MAP3K7IP2/TAB2, it forms a ternary complex with the protein kinase MAP3K7/TAK1 and either TRAF2 or TRAF6 when cells are stimulated with the pro-inflammatory cytokines TNF or IL-1. Subsequent MAP3K7/TAK1 kinase activity triggers a signalling cascade that leads to activation of the NF-kappaB transcription factor.
The TAB3 gene is classed by HGNC in the groups zinc fingers RANBP2-type and CUE domain containing. The human genome also contains a related pseudogene, which is worth bearing in mind when designing nucleic acid-based experiments. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. The mouse ortholog is named Tab3.
The approved full name is TGF-beta activated kinase 1 (MAP3K7) binding protein 3. Earlier names include mitogen-activated protein kinase kinase kinase 7 interacting protein 3, and the symbol MAP3K7IP3 is still used as an alias. UniProt notes that TAB3 may be an oncogenic factor. Related adaptors in the same signalling axis include TAB1 and TAB2, the latter being the functionally redundant partner of TAB3.
TAB3 functions in the NF-kappaB signal transduction pathway, making it a relevant adaptor for studying how pathway activation is initiated.
TAB3 forms a ternary complex with MAP3K7/TAK1 and TRAF2 or TRAF6, so it is used to study assembly of this signalling complex.
Complex formation involving TAB3 occurs in response to the pro-inflammatory cytokines TNF and IL-1, linking the protein to inflammatory signalling.
UniProt notes that TAB3 may be an oncogenic factor, which motivates investigation of its role in tumour biology.
TAB3 functions in the NF-kappaB signal transduction pathway. With TAB2, it forms a ternary complex with MAP3K7/TAK1 and either TRAF2 or TRAF6 after TNF or IL-1 stimulation. TAK1 kinase activity then triggers a cascade that activates the NF-kappaB transcription factor.
TAB3 is also known as MAP3K7IP3. Earlier names include mitogen-activated protein kinase kinase kinase 7 interacting protein 3 and TGF-beta activated kinase 1/MAP3K7 binding protein 3. RefSeq notes alternatively spliced transcript variants, though their biological validity has not been determined.
A mouse ortholog, Tab3, is recorded for the human gene; check the datasheet of any product for its validated reactivity. UniProt states that TAB3 may be an oncogenic factor. The human genome also contains a related pseudogene.
Other TAK1-binding adaptors involved in cytokine-driven NF-kappaB signalling with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8N5C8; product specifications from Assay Genie datasheets.